MDLinx Family Medicine stands out from other primary care literature review services because of our dedication to keeping our members current in less time. On a daily basis, receive an email with just the ‘headlines’ covering everything important that published in your specialty in the past 24 hours. Or, choose to Focus On the top articles published in the hottest topics in primary care, such as heart failure, depression, diabetes mellitus, eczema/psoriasis, infectious diseases, rheumatoid arthritis, COPD, and many more.
Additional bonus content is also available on this page, including clinical pearls from The Smartest Family Physician, a daily quiz competition from the editors of MDLinx Internal Medicine in collaboration with the Cleveland Clinic Center for Continuing Education. Additionally, enjoy the can’t-miss articles highlighted by our own physician editor, D. Scott Cunningham, MD, PhD.
Your Unread Messages in Family Medicine
See All >> Messages include industry-sponsored communications and special communications from MDLinx
D Scott Cunningham MD, PhD
Site Editor, MDLinx
Outcome in MI patients with hyponatremia
Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage
Smartest Doc Challenge
MDLinx
Melanoma Clinical Pearls
MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools
MDLinx Top Read
MDLinx
Running from that pile of unread journals?
921 Do Novel Psychoactive Substances Displace Established Club Drugs, Supplement Them or Act as Drugs of Initiation The relationship between Mephedrone, Ecstasy and Cocaine European Addiction Research, April 22, 2013 Clinical Article
922 Evaluation of GPs diagnostic knowledge and treatment practice in detection and treatment of early schizophrenia: a French postal survey in Brittany Social Psychiatry and Psychiatric Epidemiology, April 22, 2013 Clinical Article
923 Parents experience of living with and caring for an adult son or daughter with schizophrenia at home in Ireland: a qualitative study Journal of Psychiatric and Mental Health Nursing, April 22, 2013 Clinical Article
924 A randomised, controlled trial of a dietary intervention for adults with major depression (the SMILES trial): study protocol Full Text BMC Psychiatry, April 19, 2013 Clinical Article
925 Daily Life Behaviors and Depression Risk Following Stroke: A Preliminary Study Using Ecological Momentary Assessment Journal of Geriatric Psychiatry and Neurology, April 19, 2013 Clinical Article
926 The Treatment of Depressed Chinese Americans Using Qigong in a Health Care Setting: A Pilot Study Full Text Evidence-based Complementary and Alternative Medicine , April 19, 2013 Clinical Article
927 Sense of Coherence, Depressive Symptoms, Cardiovascular Diseases, and All-Cause Mortality Psychosomatic Medicine, April 19, 2013 Clinical Article
928 Smoking-related disease risk, area deprivation and health behaviours Journal of Public Health, April 19, 2013 Clinical Article
929 Post-Traumatic Stress Disorder: Review of the Comprehensive Soldier Fitness Program American Journal of Preventive Medicine, April 19, 2013 Review Article
930 Motivations to quit cannabis use in an adult non-treatment sample: Are they related to relapse? Addictive Behaviours, April 19, 2013 Clinical Article
931 A Pilot Study Describing Physical Activity in Persons with Schizophrenia Spectrum Disorders (SSDS) after an Exercise Program Issues in Mental Health Nursing, April 19, 2013 Clinical Article
932 The effectiveness of booster sessions in CBT treatment for child and adolescent mood and anxiety disorders Depression and Anxiety, April 19, 2013 Clinical Article
933 Childhood Abuse and Neglect in an Outpatient Clinical Sample: Prevalence and Impact American Journal of Family Therapy, April 19, 2013 Clinical Article
934 Contribution of psychiatric illness and substance abuse to 30-day readmission risk Journal of Hospital Medicine, April 19, 2013 Clinical Article
935 Personality, physical activity, and symptoms of anxiety and depression: the HUNT study Social Psychiatry and Psychiatric Epidemiology, April 19, 2013 Clinical Article
936 Use and need for psychosocial support in cancer patients Cancer, April 19, 2013 Clinical Article
937 Antipsychotics can modulate the cytokine profile in schizophrenia: Attenuation of the type-2 inflammatory response Schizophrenia Research, April 19, 2013 Clinical Article
938 Step One within Stepped Care Trauma-Focused Cognitive Behavioral Therapy for Young Children: A Pilot Study Child Psychiatry and Human Development, April 19, 2013 Clinical Article
939 Spontaneous labelling and stigma associated with clinical characteristics of peers at-risk for psychosis Early Intervention in Psychiatry, April 19, 2013 Clinical Article
940 TPH1 A218C polymorphism and temperament in major depression Full Text BMC Psychiatry, April 19, 2013 Clinical Article
In a 12-week randomized, controlled trial, ingestion of a vitamin D-fortified yogurt (170 mg calcium + 500 IU vitamin D/250 mL; n=50) twice daily decreased markers of inflammation compared with placebo yogurt (170 mg calcium; n=50). Compared with baseline measures, the 25(OH)D levels were increased and the TNF-alpha, IL-6, hsCRP, SAA, and IL-10 levels were decreased in the group supplemented with vitamin D compared with the group that received placebo.
Read the article summaryResearchers at the University of Palermo conducted a study involving 9109 subjects with a mean follow-up of 6.2 years which showed that the subjects who adhered to a Mediterranean diet had increased dietary fiber, decreased total dietary fat, and an increased intake of monosaturated-to-saturated fats. Further, the incidence of diabetes, cardiovascular events, and all-cause mortality was lower in the subjects who followed a Mediterranean diet.
Read the article summaryBased on a retrospective study conducted at the Federico II University (Naples), researchers have concluded that treatment of patients (n=84) with relapsing-remitting MS natalizumab for 12-24 months resulted in a greater reduction in disease activity (annualized relapse rate, .24 vs. .55, respectively) and disability progression than patients treated with INF-? 1a. The number of contrast-enhancing lesions was also less in the natalizumab-treated group.
Read the article summaryIndexed Journals in Family Medicine: American Family Physician, Archives of Family Med, Annals of Family Med more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close